Today's treatment of ankylosing spondylitis
Fellman, N.
Schweizerische Rundschau für Medizin Praxis 67(25): 937-943
1978
ISSN/ISBN: 1013-2058 PMID: 662829 Document Number: 124575
Document emailed within 1 workday
Related Documents
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Clegg, D.O. 2006: Treatment of ankylosing spondylitis Journal of Rheumatology. Suppl 78: 24-31
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Grasedyck, K.; Schattenkirchner, M.; Bandilla, K. 1990: The treatment of ankylosing spondylitis with auranofin (Ridaura) Zeitschrift für Rheumatologie 49(2): 98-99
Doury, P.; Pattin, S. 1980: Anti-inflammatory treatment of ankylosing spondylitis La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 56(1-2): 89-91
Chen, L.-H.; Kao, F.-C.; Niu, C.-C.; Lai, P.-L.; Fu, T.-S.; Chen, W.-J. 2005: Surgical treatment of spinal pseudoarthrosis in ankylosing spondylitis Chang Gung Medical Journal 28(9): 621-628
Demetriades, P.; Wesiroglou, G.; Mitseas, C.; Kontomerkos, A. 1973: Cyclophosphamide in the treatment of ankylosing spondylitis, a study on 66 cases Zeitschrift für Allgemeinmedizin 49(25): 1182-1186
Brandt, J.; Sieper, J.; Braun, J. 2002: Infliximab in the treatment of active and severe ankylosing spondylitis Clinical and Experimental Rheumatology 20(6 Suppl 28: S106-S110
Cywińska, M.; Jadwiga, W.; Prochowicz, Z. 1977: Use of lignocaine phonophoresis and electrophoresis in the treatment of patients with ankylosing spondylitis Polski Tygodnik Lekarski 32(27): 1051-1053
Mohing, W. 1974: Possibilities of surgical treatment in chronic polyarthritis and ankylosing spondylitis Der Internist 15(6): 312-321
Bessant, R.; Harris, C.; Keat, A. 2003: Audit of the diagnosis, assessment, and treatment of osteoporosis in patients with ankylosing spondylitis Journal of Rheumatology 30(4): 779-782
Franović, A. 1980: A critical review of modern methods of dosing in the functional treatment of ankylosing spondylitis Reumatizam 27(3): 72-79
Stone, M.; Salonen, D.; Lax, M.; Payne, U.; Lapp, V.; Inman, R. 2001: Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis Journal of Rheumatology 28(7): 1605-1614
Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923
Famenini, S.; Wu, J.J. 2013: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases Journal of Drugs in Dermatology: Jdd 12(8): 939-943